Systemic sclerosis patients‘ sera recognize collagen V in experimental scleroderma lung fibrosis

N. Borsonello, A. P. Velosa, P. Martin, R. Marangoni, S. Carrasco, E. Parra, V. Capelozzi, N. Yoshinari, W. Teodoro (São Paulo, Brazil)

Source: Annual Congress 2011 - The ageing pulmonary interstitium
Session: The ageing pulmonary interstitium
Session type: Thematic Poster Session
Number: 785
Disease area: Interstitial lung diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
N. Borsonello, A. P. Velosa, P. Martin, R. Marangoni, S. Carrasco, E. Parra, V. Capelozzi, N. Yoshinari, W. Teodoro (São Paulo, Brazil). Systemic sclerosis patients‘ sera recognize collagen V in experimental scleroderma lung fibrosis. Eur Respir J 2011; 38: Suppl. 55, 785

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Auto-antibody subsets and extent of pulmonary fibrosis in systemic sclerosis (SSc)
Source: Eur Respir J 2005; 26: Suppl. 49, 202s
Year: 2005

Collagen V and decorin is involved in systemic sclerosis pulmonary fibrosis
Source: Annual Congress 2011 - The ageing pulmonary interstitium
Year: 2011

Interstitial lung diseases in collagen vascular diseases
Source: Eur Respir J 2001; 18: 69S-80S
Year: 2001



Collagen V nasal tolerance promotes decrease in topoisomerase-1 and pulmonary fibrosis of systemic sclerosis model
Source: Annual Congress 2010 - Experimental approaches in pulmonary fibrosis
Year: 2010


Autoantibodies to the surfactant protein D in patients with interstitial lung diseases associated with amyopathic dermatomyositis and systemic sclerosis
Source: Annual Congress 2008 - Interstitial lung disease in systemic and vascular disorders
Year: 2008

Anti-a-enolase antibodies in systemic sclerosis identify a subset of patients with diffuse cutaneous sclerosis and interstitial lung disease
Source: Annual Congress 2008 - Interstitial lung disease in systemic and vascular disorders
Year: 2008

Nintedanib inhibits fibroblast activation and ameliorates pulmonary and dermal fibrosis in models of systemic sclerosis (SSc)
Source: International Congress 2015 – IPF: from bench to bedside
Year: 2015

Clinical characteristics of interstitial lung fibrosis in progressive systemic sclerosis
Source: Eur Respir J 2006; 28: Suppl. 50, 95s
Year: 2006

Increased mRNA expression of collagen V gene in pulmonary fibrosis of systemic sclerosis
Source: Annual Congress 2009 - Bronchoalveolar lavage and phenotyping in diffuse parenchymal lung disease
Year: 2009


Clinical manifestations of systemic sclerosis (SS) accompanied with pulmonary involvement
Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease
Year: 2013


Oral immunotherapy with type V collagen in idiopathic pulmonary fibrosis
Source: Eur Respir J 2015; 45: 1393-1402
Year: 2015



Abnormal collagen type V deposition in lung fibroblast is correlated with a worse pulmonary function in systemic sclerosis
Source: Annual Congress 2007 - Miscellaneous interstitial lung diseases related to systemic and other diseases
Year: 2007


Clinical features and CT findings of anti-Jo-1 antibody positive interstitial lung disease with or without polymyositis and dermatomyositis
Source: Annual Congress 2013 –Diffuse parenchymal lung disease III
Year: 2013


Relationship between MIF and cellular pattern in BAL of patients with sarcoidosis, systemic sclerosis, idiopathic pulmonary fibrosis
Source: Eur Respir J 2003; 22: Suppl. 45, 377s
Year: 2003

Interstitial lung disease in systemic sclerosis: where do we stand?
Source: Eur Respir Rev 2015; 24: 411-419
Year: 2015



Genomic comparison of fibrotic rheumatoid arthritis-associated ILD and idiopathic pulmonary fibrosis
Source: International Congress 2015 – Connective tissue disorders
Year: 2015

Immunosuppression for interstitial lung disease in systemic sclerosis},
Source: Eur Respir Rev 2013; 22: 236-243
Year: 2013



Interstitial lung disease with ANCA-associated vasculitis (AAV-ILD): Clinical features and survival compared to patients with ILD associated with systemic sclerosis and IPF
Source: Virtual Congress 2020 – Addressing unresolved questions in rare diffuse parenchymal lung diseases: interdisciplinary research is the key
Year: 2020

Pulmonary interstitium remodeling by collagen V is associated with profibrotic cytocines in experimental systemic sclerosis
Source: Annual Congress 2007 - Miscellaneous interstitial lung diseases related to systemic and other diseases
Year: 2007


Systemic autoimmunity and  pulmonary fibrosis
Source: International Congress 2017 – GR3 Scientific Grand Round: Autoimmunity in chronic lung disease
Year: 2017